Gerresheimer Aktie
WKN DE: A0LD6E / ISIN: DE000A0LD6E6
15.03.2024 08:22:05
|
EQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQS Preliminary announcement financial reports: Gerresheimer AG
/ Preliminary announcement on the disclosure of financial statements
Gerresheimer AG hereby announces that the following financial reports shall be disclosed:
Report Type: Quarterly financial report within the 1st half-year (Q1) Language: German Date of disclosure: April 11, 2024 Address: https://www.gerresheimer.com/unternehmen/investor-relations/berichte Language: English Date of disclosure: April 11, 2024 Address: https://www.gerresheimer.com/en/company/investor-relations/reports Report Type: Quarterly financial report within the 2nd half-year (Q3) Language: German Date of disclosure: October 10, 2024 Address: https://www.gerresheimer.com/unternehmen/investor-relations/berichte Language: English Date of disclosure: October 10, 2024 Address: https://www.gerresheimer.com/en/company/investor-relations/reports
15.03.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Gerresheimer AG |
Klaus-Bungert-Str. 4 | |
40468 Duesseldorf | |
Germany | |
Internet: | http://www.gerresheimer.com |
End of News | EQS News Service |
|
1855739 15.03.2024 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Gerresheimer AGmehr Nachrichten
09:29 |
Minuszeichen in Frankfurt: MDAX zum Start im Minus (finanzen.at) | |
08:15 |
EQS-DD: Gerresheimer AG: Dietmar Siemssen, buy (EQS Group) | |
08:15 |
EQS-DD: Gerresheimer AG: Dietmar Siemssen, Kauf (EQS Group) | |
13.10.25 |
EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group) | |
13.10.25 |
ANALYSE-FLASH: JPMorgan senkt Ziel für Gerresheimer auf 46 Euro - 'Overweight' (dpa-AFX) | |
13.10.25 |
EQS-News: Gerresheimer: FDA erteilt Zulassung für Lasix® ONYU* von SQ Innovation (EQS Group) | |
13.10.25 |
EQS-News: Gerresheimer: FDA grants Approval of SQ Innovation’s Lasix® ONYU* (EQS Group) | |
10.10.25 |
Gerresheimer-Aktie tiefer: Verkauf von Moulded-Glass-Geschäft für 2026 angepeilt (Dow Jones) |
Analysen zu Gerresheimer AGmehr Analysen
09:50 | Gerresheimer Neutral | UBS AG | |
13.10.25 | Gerresheimer Overweight | JP Morgan Chase & Co. | |
13.10.25 | Gerresheimer Hold | Deutsche Bank AG | |
10.10.25 | Gerresheimer Verkaufen | DZ BANK | |
10.10.25 | Gerresheimer Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Gerresheimer AG | 28,16 | -2,09% |
|